These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34674772)

  • 1. Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward.
    Bardhan M; Hasan MM; Ray I; Sarkar A; Chahal P; Rackimuthu S; Essar MY
    Trop Med Health; 2021 Oct; 49(1):84. PubMed ID: 34674772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.
    Mergenthaler C; Bhatnagar A; Dong D; Kumar V; Lakis C; Mutasa R; Dapkekar S; Sahore A; Surendran S; Fritsche G; Sachdeva KS; Dieleman M
    BMC Health Serv Res; 2024 Aug; 24(1):907. PubMed ID: 39113002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to treatment adherence for female Tuberculosis (TB) patients during the COVID-19 pandemic: Qualitative evidence from front-line TB interventions in Bengaluru City, India.
    George S; Paranjpe A; Nagesh P; Saalim M
    Indian J Public Health; 2022; 66(1):38-44. PubMed ID: 35381712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Tuberculosis Mortality Across India: Improvements Despite the COVID-19 Pandemic.
    Varshney K; Patel H; Kamal S
    Cureus; 2023 Apr; 15(4):e38313. PubMed ID: 37261163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 on tuberculosis services: an experience from a tertiary care hospital.
    Jamwal A; Mohanty A; Swami A; Turbadkar D
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35737515
    [No Abstract]   [Full Text] [Related]  

  • 6. The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis.
    Subbaraman R; Nathavitharana RR; Satyanarayana S; Pai M; Thomas BE; Chadha VK; Rade K; Swaminathan S; Mayer KH
    PLoS Med; 2016 Oct; 13(10):e1002149. PubMed ID: 27780217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. India Unburdening the Pandemic: Jabs and Talks.
    Basu E; Raj MP; Krishnamurthy V
    Cureus; 2023 Jun; 15(6):e40991. PubMed ID: 37503498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa.
    Loveday M; Cox H; Evans D; Furin J; Ndjeka N; Osman M; Naidoo For The National Tb Think Tank 'Optimising Tb Treatment Outcomes' Task Team K
    S Afr Med J; 2020 Nov; 110(12):1160-1167. PubMed ID: 33403958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating health planning and primary care infrastructure for COVID-19 and tuberculosis care in India: Challenges and opportunities.
    Yadav P; Vohra C; Gopalakrishnan M; Garg MK
    Int J Health Plann Manage; 2022 Mar; 37(2):632-642. PubMed ID: 34820907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India.
    Hazra D; Chawla K; Shenoy VP; Pandey AK; S N
    J Infect Public Health; 2021 Aug; 14(8):1095-1098. PubMed ID: 34274858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health system resilience: Ensuring TB services during COVID-19 pandemic in Kerala, India.
    Khobragade RN; Kelkar RU; Sunilkumar M; Cency B; Murthy N; Surendran D; Rakesh PS; Balakrishnan S
    Indian J Tuberc; 2022 Oct; 69(4):427-431. PubMed ID: 36460371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid DOTS expansion in India.
    Khatri GR; Frieden TR
    Bull World Health Organ; 2002; 80(6):457-63. PubMed ID: 12132002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 on the national tuberculosis elimination program in uttarakhand, india: a mixed-methods research study.
    Garg K; Bahurupi Y; Aggarwal P; Badola M
    Infect Prev Pract; 2023 Mar; 5(1):100269. PubMed ID: 36718460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragility and challenges of health systems in pandemic: lessons from India's second wave of coronavirus disease 2019 (COVID-19).
    Malik MA
    Glob Health J; 2022 Mar; 6(1):44-49. PubMed ID: 35070474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TB free India: Reaching the unreached tribal population under National Tuberculosis Elimination Programme.
    Bhat J; Rao R; Kumar R; Yadav R; Singh P; Rao VG; Das A
    Indian J Tuberc; 2022 Jan; 69(1):4-7. PubMed ID: 35074149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the perspectives of members of international tuberculosis control and research networks on the impact of COVID-19 on tuberculosis services: a cross sectional survey.
    Nkereuwem O; Nkereuwem E; Fiogbe A; Usoroh EE; Sillah AK; Owolabi O; Tebruegge M; Badjan A; Kampmann B; Togun T
    BMC Health Serv Res; 2021 Aug; 21(1):798. PubMed ID: 34384439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward.
    Meghana A; Aparna Y; Chandra SM; Sanjeev S
    Res Social Adm Pharm; 2021 Jan; 17(1):2018-2022. PubMed ID: 32362583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TB care for women and Covid-A double health crisis in the offing?
    Suresh R; Ruban S; Kumar S
    Health Care Women Int; 2020; 41(11-12):1226-1239. PubMed ID: 33616508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research.
    Mistry N; Tolani M; Osrin D
    Oper Res Health Care; 2012 Jun; 1(2-3):45-53. PubMed ID: 24501697
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.